ICN 600 Pill - pink capsule/oblong, 19mm
Generic Name: methoxsalen
Pill with imprint ICN 600 is Pink, Capsule/Oblong and has been identified as 8-mop 10 mg. It is supplied by ICN Pharmaceuticals Inc.
8-MOP is used in the treatment of Cutaneous T-cell Lymphoma; Psoriasis and belongs to the drug class psoralens. There is positive evidence of human fetal risk during pregnancy. 8-MOP 10 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for ICN 600
8-mop
- Generic Name
- methoxsalen
- Imprint
- ICN 600
- Strength
- 10 mg
- Color
- Pink
- Size
- 19.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Psoralens
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- ICN Pharmaceuticals Inc
- National Drug Code (NDC)
- 00187-0651 (Discontinued)
- Inactive Ingredients
-
corn starch
Note: Inactive ingredients may vary.
See also:
Stelara
Stelara (ustekinumab) is used to treat Crohn's disease, ulcerative colitis, plaque psoriasis, and ...
Cosentyx
Cosentyx (secukinumab) is used to treat plaque psoriasis, psoriatic arthritis, ankylosing ...
Skyrizi
Skyrizi (risankizumab) is used to treat plaque psoriasis, psoriatic arthritis, ulcerative colitis ...
Humira
Humira is a tumor necrosis factor blocker used to treat many inflammatory conditions in adults ...
Ilumya
Ilumya (tildrakizumab) is used to treat moderate-to-severe plaque psoriasis to reduce plaques ...
Taltz
Taltz (ixekizumab) is used to treat plaque psoriasis, psoriatic arthritis, and ankylosing ...
Zolinza
Zolinza is used to treat skin problems caused by cutaneous T-cell lymphoma. Learn about side ...
Actimmune
Actimmune is used for chronic granulomatous disease, cutaneous t-cell lymphoma, idiopathic ...
More about 8-MOP (methoxsalen)
- Check interactions
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: psoralens
- Breastfeeding
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.